(Q44059652)

English

Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants (English)

1 reference

Europe PubMed Central

29 November 2017

Vaccination of dogs

1 reference

based on heuristic

inferred from title

author name string

J Poot

1

1 reference

Europe PubMed Central

29 November 2017

L H M Janssen

2

1 reference

Europe PubMed Central

29 November 2017

T J van Kasteren-Westerneng

3

1 reference

Europe PubMed Central

29 November 2017

K H A van der Heijden-Liefkens

4

1 reference

Europe PubMed Central

29 November 2017

V E J C Schijns

5

1 reference

Europe PubMed Central

29 November 2017

A Heckeroth

6

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

3 June 2009

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

27

1 reference

Europe PubMed Central

29 November 2017

33

1 reference

Europe PubMed Central

29 November 2017

4439-4446

1 reference

Europe PubMed Central

29 November 2017

Chemotherapy of canine leishmaniosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Cloning of a ribosomal phosphoprotein P0 gene homologue from Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Translocation of ribosomal protein P0 onto the Toxoplasma gondii tachyzoite surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Modulation of the pattern of development of experimental disseminated leishmaniasis by Corynebacterium parvum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Leishmania tropica major in mice: vaccination against cutaneous leishmaniasis in mice of high genetic susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Aluminium adjuvants--in retrospect and prospect

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Comparative genomic analysis of three Leishmania species that cause diverse human disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

A simple monophasic medium for axenic culture of hemoflagellates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Regulations and procedures in parasite vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.043

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.05.043

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44059652&oldid=2106124474"